SHR-1811
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SHR-1811, covering 2025-07-02 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: MA-CRC-II-016 SHR-1811 [Phase 2]
2 regulatory and trial events tracked for SHR-1811, covering 2025-07-02 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: MA-CRC-II-016 SHR-1811 [Phase 2]